Caribou Biosciences Inc. (CRBU) is priced at $11.63 after the most recent trading session. At the very opening of the session, the stock price was $13.13 and reached a high price of $13.13, prior to closing the session it reached the value of $12.85. The stock touched a low price of $11.56.Recently in News on January 4, 2022, Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference. Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel Haurwitz, Ph.D., Caribou’s president and chief executive officer, will present a corporate update at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 9:45 am ET. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Caribou Biosciences Inc. shares are logging -64.37% during the 52-week period from high price, and -4.67% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.20 and $32.65.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 637655 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Caribou Biosciences Inc. (CRBU) recorded performance in the market was -22.93%, having the revenues showcasing -48.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 689.89M, as it employees total of 76 workers.
The Analysts eye on Caribou Biosciences Inc. (CRBU)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 20.83, with a change in the price was noted -17.61. In a similar fashion, Caribou Biosciences Inc. posted a movement of -60.23% for the period of last 100 days, recording 530,103 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRBU is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Caribou Biosciences Inc. (CRBU)
Raw Stochastic average of Caribou Biosciences Inc. in the period of last 50 days is set at 0.57%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.22%. In the last 20 days, the company’s Stochastic %K was 9.56% and its Stochastic %D was recorded 10.31%.
Considering, the past performance of Caribou Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -22.93%. The shares increased approximately by -9.28% in the 7-day charts and went up by -29.56% in the period of the last 30 days. Common stock shares were lifted by -48.52% during last recorded quarter.